Literature DB >> 1165121

Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

G A Cabral, R Chairez, F Marciano-Cabral, M Suarez, G R Dreesman, J L Melnick, F B Hollinger.   

Abstract

Guinea pigs immunized wit- hepatitis B surface antigen (HBSAg), types adw and ayw, and with two polypeptides (400,000 and 24,000 molecular weight) developed cell-mediated immunity (CMI), as determined by radioimmunoassay. Peritoneal exudate (PE) cells from guinea pigs immunized with the 40,000-molecular-weight polypeptide migrated poorly (30 to 88% inhibition) after challenge with the immunizing subunit or with purified HBSAg, type gdw or ayw. Response of the same PE cells to the 24,000-molecular-weight subunit was significantly reduced. Similar but less striking evidence for CMI was observed was PE cells derived from guinea pigs inoculated with purified type-specific HBSAg or with the 24,000-molecular-weight polypeptide. Humoral responses were predictable and showed a reasonable degree of correlation with the CMI response. PE cells from control animals inoculated with normal human serum or polyacrylamide gel were not inhibited after challenge with purified preparations of HBSAg or with the 400,000-molecular-weight polypeptide, but did show CMI with their respective immunogens. In addition, PE cells from guinea pigs inoculated with normal human serum were inhibited from migrating after challenge with the 24,000-molecular-weight subunit, suggesting that the latter may contain an antigenic determinant related to a human serum protein.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165121      PMCID: PMC415324          DOI: 10.1128/iai.12.3.564-570.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Biophysical properties of purified morphologic forms of hepatitis B antigen.

Authors:  R Chairez; F B Hollinger; J L Melnick; G R Dreesman
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

2.  Staphylococcal radioimmunoassay for hepatitis B antigen and antibody.

Authors:  K J Figenschau; J C Ulstrup
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

3.  In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA.

Authors:  G N Vyas; A B Ibrahim; K R Rao; V Likhite
Journal:  Nature       Date:  1974-02-08       Impact factor: 49.962

4.  Glycoproteins associated with hepatitis B antigen.

Authors:  R Chairez; S Steiner; J L Melnick; G R Dreesman
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

5.  Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen.

Authors:  G R Dreesman; R Chairez; M Suarez; F B Hollinger; R J Courtney; J L Melnick
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

6.  Delayed hypersensitivity to hepatitis-associated antigen in guinea pigs.

Authors:  G R Irwin; W J Hierholzer; R W McCollum
Journal:  J Infect Dis       Date:  1972-01       Impact factor: 5.226

7.  Four antigenic variants of blood group A glycolipid: examples of highly complex, branched chain glycolipid of animal cell membrane.

Authors:  S Hakomori; K Stellner; K Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

8.  Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.

Authors:  G R Dreesman; F B Hollinger; R M McCombs; J L Melnick
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

9.  Major polar lipids of hepatitis B antigen preparations: evidence for the presence of a glycosphingolipid.

Authors:  S Steiner; M T Huebner; G R Dreesman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

10.  Cell-mediated immunity in patients positive for hepatitis-associated antigen.

Authors:  F J Dudley; V Giustino; S Sherlock
Journal:  Br Med J       Date:  1972-12-30
View more
  3 in total

1.  Polypeptide composition of HBsag.

Authors:  E Mineva; M Teoharova; S Ditzov; S Todorov
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.

Authors:  Y Sanchez; I Ionescu-Matiu; G R Dreesman; W Kramp; H R Six; F B Hollinger; J L Melnick
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

3.  Immunization of chimpanzees with hepatitis B virus-derived polypeptides.

Authors:  G R Dreesman; F B Hollinger; Y Sanchez; P Oefinger; J L Melnick
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.